Laura Chico
Stock Analyst at Wedbush
(4.79)
# 555
Out of 4,690 analysts
634
Total ratings
53.5%
Success rate
15.7%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLYM Climb Bio | Maintained: Buy | $20 | $14.57 | +37.27% | 7 | Aug 19, 2026 | |
| VERA Vera Therapeutics | Maintained: Hold | $34 | $34.19 | -0.56% | 13 | Aug 17, 2026 | |
| OVID Ovid Therapeutics | Maintained: Buy | $7 | $2.80 | +150.00% | 13 | Aug 14, 2026 | |
| GOSS Gossamer Bio | Maintained: Hold | $1 | $0.1701 | +487.89% | 8 | Aug 14, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $48 | $27.44 | +74.93% | 7 | Aug 12, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $47 | $20.84 | +125.53% | 12 | Aug 11, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | $53 → $5 | $5.87 | -14.82% | 4 | Aug 10, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $21 → $20 | $9.82 | +103.67% | 17 | Aug 6, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $61 → $75 | $65.67 | +14.21% | 35 | Aug 6, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $43 → $41 | $23.08 | +77.64% | 74 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 | $25.61 | +17.14% | 55 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $11 | $4.01 | +174.31% | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $122 | $105.84 | +15.27% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $185 → $194 | $154.06 | +25.92% | 25 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $201 → $215 | $218.50 | -1.60% | 69 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $3.81 | +398.69% | 20 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $26 | $24.00 | +8.33% | 27 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $42.76 | +21.61% | 23 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $166 → $162 | $344.75 | -53.01% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $9.77 | +63.77% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $35.13 | -31.68% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $35.32 | +18.91% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $4 | $3.08 | +29.87% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $59.99 | +5.02% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $31.62 | +20.18% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $15.59 | +156.57% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $3.54 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $16.81 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $15.11 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $5 | $5.77 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $4.52 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $45 | $1.06 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $64.67 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $541.69 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.40 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.70 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $794.19 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $10.91 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.2853 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $59.14 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $1.82 | n/a | 1 | Jun 30, 2017 |
Climb Bio
Aug 19, 2026
Maintained: Buy
Price Target: $20
Current: $14.57
Upside: +37.27%
Vera Therapeutics
Aug 17, 2026
Maintained: Hold
Price Target: $34
Current: $34.19
Upside: -0.56%
Ovid Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $7
Current: $2.80
Upside: +150.00%
Gossamer Bio
Aug 14, 2026
Maintained: Hold
Price Target: $1
Current: $0.1701
Upside: +487.89%
Maze Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $48
Current: $27.44
Upside: +74.93%
Jade Biosciences
Aug 11, 2026
Maintained: Buy
Price Target: $47
Current: $20.84
Upside: +125.53%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: $53 → $5
Current: $5.87
Upside: -14.82%
BioCryst Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $21 → $20
Current: $9.82
Upside: +103.67%
Travere Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $61 → $75
Current: $65.67
Upside: +14.21%
Viridian Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $43 → $41
Current: $23.08
Upside: +77.64%
Aug 5, 2026
Maintained: Hold
Price Target: $30
Current: $25.61
Upside: +17.14%
Aug 5, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $4.01
Upside: +174.31%
Aug 5, 2026
Maintained: Buy
Price Target: $105 → $122
Current: $105.84
Upside: +15.27%
Aug 3, 2026
Maintained: Buy
Price Target: $185 → $194
Current: $154.06
Upside: +25.92%
Jul 31, 2026
Maintained: Hold
Price Target: $201 → $215
Current: $218.50
Upside: -1.60%
Jul 13, 2026
Maintained: Buy
Price Target: $19
Current: $3.81
Upside: +398.69%
Jul 13, 2026
Maintained: Buy
Price Target: $23 → $26
Current: $24.00
Upside: +8.33%
Jun 17, 2026
Maintained: Buy
Price Target: $52
Current: $42.76
Upside: +21.61%
Jun 2, 2026
Maintained: Sell
Price Target: $166 → $162
Current: $344.75
Upside: -53.01%
May 18, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $9.77
Upside: +63.77%
May 14, 2026
Maintained: Hold
Price Target: $21 → $24
Current: $35.13
Upside: -31.68%
May 13, 2026
Maintained: Buy
Price Target: $42
Current: $35.32
Upside: +18.91%
May 13, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $3.08
Upside: +29.87%
May 8, 2026
Maintained: Buy
Price Target: $63
Current: $59.99
Upside: +5.02%
May 8, 2026
Maintained: Buy
Price Target: $38
Current: $31.62
Upside: +20.18%
May 7, 2026
Reiterated: Buy
Price Target: $40
Current: $15.59
Upside: +156.57%
Aug 7, 2024
Maintained: Hold
Price Target: $8 → $7
Current: $3.54
Upside: n/a
Apr 11, 2024
Maintained: Buy
Price Target: $13 → $11
Current: $16.81
Upside: n/a
Mar 20, 2024
Maintained: Hold
Price Target: $5
Current: $15.11
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $22 → $5
Current: $5.77
Upside: n/a
Feb 11, 2022
Maintained: Buy
Price Target: $23
Current: $4.52
Upside: n/a
Aug 11, 2020
Maintained: Hold
Price Target: $3 → $45
Current: $1.06
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $64.67
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $541.69
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $15.40
Upside: n/a
Aug 13, 2018
Maintained: Hold
Price Target: n/a
Current: $1.70
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: n/a
Current: $794.19
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $10.91
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.2853
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $59.14
Upside: n/a
Jun 30, 2017
Maintained: Buy
Price Target: $30
Current: $1.82
Upside: n/a